Swedish Orphan Biovit Ord
(BIOVF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 500,848 | 561,315 | 379,505 | 393,802 | 527,468 |
| Cost of Goods | 102,005 | 118,859 | 88,447 | 103,632 | 162,364 |
| Gross Profit | 398,843 | 442,456 | 291,058 | 290,170 | 365,104 |
| Operating Expenses | 256,022 | 257,967 | 225,170 | 247,825 | 282,358 |
| Operating Income | 142,922 | 185,447 | 66,335 | 42,977 | 83,110 |
| Interest Expense | 16,252 | 14,849 | 12,812 | 10,668 | 10,924 |
| Other Income | 0 | 597 | 0 | -102 | 0 |
| Pre-tax Income | 126,670 | 171,195 | 53,524 | 32,207 | 72,185 |
| Income Tax | 24,665 | 36,836 | 10,724 | 6,096 | 14,030 |
| Net Income Continuous | 102,005 | 134,359 | 42,800 | 26,111 | 58,155 |
| Net Income | $102,005 | $134,258 | $42,800 | $26,213 | $58,155 |
| EPS Basic Total Ops | 0.34 | 0.45 | 0.14 | 0.09 | 0.20 |
| EPS Basic Continuous Ops | 0.34 | 0.45 | 0.14 | 0.09 | 0.20 |
| EPS Diluted Total Ops | 0.34 | 0.45 | 0.14 | 0.09 | 0.20 |
| EPS Diluted Continuous Ops | 0.34 | 0.45 | 0.14 | 0.09 | 0.20 |
| EBITDA(a) | $206,305 | $251,498 | $112,907 | $96,613 | $156,473 |